Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly’s weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder. The regulator approved the drug for moderate to severe obstructive sleep apnea in adults with obesity, the company…

Read More

Blinken makes unannounced Iraq visit as part of Syria diplomacy push

By Simon Lewis BAGHDAD (Reuters) -U.S. Secretary of State Antony Blinken made an unannounced visit to Iraq on Friday and met with Prime Minister Mohammed Shia al-Sudani to discuss Syria’s political transition, calling for a non-sectarian administration following the fall of Bashar al-Assad. The top U.S. diplomat is touring the Middle East to establish a…

Read More

Biden pushes out over $100 billion in clean energy grants as term winds down

By Valerie Volcovici WASHINGTON (Reuters) – U.S. President Joe Biden’s administration has awarded over $100 billion in grants created by its signature climate law, the Inflation Reduction Act, a senior administration official said. The administration hopes the spending milestone will help to continue the deployment of clean energy even after President-elect Donald Trump, a climate…

Read More

Chinese defense minister declines meeting with Pentagon chief

WASHINGTON (Reuters) – China’s defense minister declined a meeting with U.S. Defense Secretary Lloyd Austin during a meeting of defense leaders in Laos, a move the Pentagon chief said on Wednesday was unfortunate. Multilateral gatherings of national security officials in Asia have been used in the past for meetings between U.S. and Chinese defense leaders,…

Read More